Ankit Gupta(@agupta):Completely nuts that PBM revenue is comparable to pharma revenue in the status quo. Pharma companies take on enormous scientific and execution risk to discover and advance medicines. PBMs are unnecessary middlemen that do neither of those things.

Ankit Gupta

@agupta

general partner @ycombinator. co-founder of @reverielabs (acquired). @harvard CS. 🫶 to @lucylnam.

Joined November 2015

1.2K Following 22.1K Followers

Ankit Gupta@agupta

2026.08.17 05:46

Completely nuts that PBM revenue is comparable to pharma revenue in the status quo. Pharma companies take on enormous scientific and execution risk to discover and advance medicines. PBMs are unnecessary middlemen that do neither of those things.

126

Forward to community

Most Popular Users

746.7K Followers

1M Followers

111.9M Followers

241.7M Followers

6.3M Followers

195.8K Followers

3.4M Followers

5.4M Followers

2M Followers

470.1K Followers

1.8M Followers

2.1M Followers

348.8K Followers

9.1M Followers

1.8M Followers